
Massive Investment in Alzheimer’s Drug Kisunla
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide

Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide

In a new Alzheimer’s study, Rexulti (brexpiprazole) significantly reduced agitation. Learn the kinds of agitation it reduced and by how much.

There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

In gardening, people with Alzheimer’s grow fresh plants along with better thinking. It’s a pleasant way to make things easier.

The co-founder of a caregivers’ organization introduces technology he has found helpful in caring for his grandmother with dementia.

New research reveals that Leqembi’s Fc region switches on microglia — the brain’s immune cells — helping them clear toxic amyloid. Here’s why that mechanism matters for treatment and safety.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.

Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.
No spam, only news and updates.


